ERα instead of ERβ can participate in the invasion of ovarian cancer cells induced by leptin in an estrogen-independent manner (50), and 17β-estradiol can reverse the migration of ovarian cancer cells induced by leptin through the PI3K/Akt signaling pathway (32). Here, ESR2 is linked to ovarian carcinoma.